Optimizing Psychiatry AIM Specialty Health Integration for Prior Authorization

Achieving seamless **psychiatry AIM Specialty Health integration** is critical for efficient prior authorization workflows, ensuring timely access to essential mental health treatments and services managed by Carelon (Elevance).

Prior authorization for psychiatric services and specialty medications presents unique complexities, from managing high-volume drug categories like atypical antipsychotics and stimulants to navigating specific criteria for TMS and esketamine. When these services fall under the purview of specialty benefit managers like AIM Specialty Health, the administrative burden intensifies, requiring precise documentation and adherence to specific clinical guidelines. Klivira streamlines this intricate process, providing a robust solution for automated prior authorization submissions.

The Intersection of Psychiatry and AIM Specialty Health PA

Psychiatry prior authorization involves high-cost medications and complex services, often managed by specialty benefit organizations like AIM Specialty Health (a Carelon company, formerly Elevance Health). This integration point requires precise adherence to medical policies for treatments ranging from advanced pharmacotherapy to neuromodulation, impacting patient access and revenue cycles. Klivira's platform is designed to navigate these specific requirements, ensuring efficient processing of behavioral health authorizations.

High-Volume Psychiatry Services Requiring AIM Authorization

Specialty psychiatric medications: Long-acting injectable antipsychotics (e.g., paliperidone, aripiprazole LAI), esketamine (Spravato), brexanolone, zuranolone, naltrexone injectable.
Neuromodulation therapies: Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS).
Ketamine and esketamine clinic services, including administration.
Inpatient psychiatric admissions and continued stay, including concurrent review with InterQual or MCG behavioral criteria.
Partial hospitalization (PHP), intensive outpatient (IOP), and residential treatment for mental health and substance use disorders, often requiring ASAM criteria.

Streamlining Documentation for AIM Specialty Health Reviews

Successful authorization with AIM Specialty Health for psychiatry services relies on robust clinical documentation. Klivira's platform is engineered to support the aggregation of necessary data, aligning with APA Practice Guidelines and ASAM Criteria for SUD, which are frequently referenced by payers. This includes capturing severity scales, safety assessments, and prior treatment trials to meet specific payer policy requirements.

Critical Documentation Elements for Psychiatry PA

DSM-5-TR diagnosis and severity documentation (e.g., PHQ-9, GAD-7, Beck scales).
Safety risk assessments, including suicidal/homicidal ideation, plan, and intent.
ASAM dimension documentation across the six ASAM dimensions for substance use disorder (SUD) levels of care.
Evidence of failed antidepressant trials for TMS or prior oral medication trials for specialty injectables.
REMS documentation for restricted-dispensing drugs like esketamine, where applicable.

Klivira's Solution for Psychiatry AIM Specialty Health Integration

Klivira automates the complex prior authorization process for psychiatry services managed by AIM Specialty Health. Our platform integrates with EMRs via SMART on FHIR, extracting relevant clinical data to populate X12 278 transactions or payer portal submissions. This reduces manual data entry, minimizes common denial reasons like ASAM level mismatch or insufficient step therapy documentation, and can flag potential Mental Health Parity and Addiction Equity Act (MHPAEA) considerations.

Key Workflow Enhancements for Psychiatry PA

Automated data extraction from EMRs for psychiatric diagnoses, treatment history, and severity scores.
Real-time validation against payer-specific medical policies and clinical guidelines (e.g., ASAM Criteria, APA Practice Guidelines).
Expedited submission pathways for time-sensitive admissions and continuous concurrent reviews for inpatient/residential stays.
Proactive flagging of documentation gaps for specialty drugs and procedures, reducing rework.
Direct connectivity to payer portals and X12 278 ePA channels for efficient submissions to AIM Specialty Health.

Frequently asked questions

How does Klivira handle ASAM criteria for SUD treatment with AIM Specialty Health?

Klivira's platform incorporates ASAM-criteria-aware logic, guiding prior authorization coordinators through the necessary documentation across the six ASAM dimensions. This ensures that submissions to AIM Specialty Health for SUD treatment levels of care are aligned with payer expectations, reducing denials related to level mismatch.

Can Klivira automate PA for restricted-dispensing drugs like esketamine?

Yes, Klivira supports the automation of prior authorizations for restricted-dispensing drugs like esketamine. Our system helps ensure all required REMS documentation and specific administration site details are captured and included in the submission to AIM Specialty Health, streamlining a complex approval process.

What EMR integration capabilities does Klivira offer for psychiatry PA?

Klivira integrates with leading EMRs using SMART on FHIR standards, enabling seamless extraction of clinical data relevant to psychiatry prior authorizations. This includes diagnoses, medication lists, progress notes, and severity scales, which are then used to populate X12 278 transactions or payer portal submissions to AIM Specialty Health.

How does Klivira address step therapy requirements for TMS or specialty medications?

Klivira automates the documentation and submission process for step therapy requirements. For TMS, our system helps compile evidence of prior antidepressant trials, and for specialty injectables, it ensures documentation of oral medication trials is included, accelerating approvals from AIM Specialty Health.

Does Klivira support concurrent review for inpatient psychiatric stays?

Yes, Klivira provides robust workflow support for concurrent review processes, which are critical for inpatient and residential psychiatric stays. Our platform facilitates timely submission of continued-stay reviews to AIM Specialty Health, helping to prevent denials for ongoing care when severity criteria are met.

What specific data points does Klivira extract for psychiatry PA submissions?

Klivira extracts a comprehensive range of data points for psychiatry PA submissions, including DSM-5-TR diagnoses, PHQ-9/GAD-7 scores, safety risk assessments, medication history, prior treatment trials, and ASAM dimension documentation. This data is then structured for efficient submission to AIM Specialty Health.